A 45-year-old male with Vogt-Koyanagi-Harada (VKH) syndrome presented with vision loss in his right eye after discontinuing treatment during the COVID-19 pandemic. He was found to have bullous retinal detachment (RD) in the right eye and was started on subcutaneous adalimumab with oral corticosteroid following three doses of pulse corticosteroid. But when RD did not resolve after 4 months of treatment and ultrasound B scan showed bullous RD with retino-retinal adhesion, he was planned for surgical intervention. During surgery, there was retino-retinal adhesions due to long-standing "kissing exudative RD", causing non-settling exudative RD. Following surgery, the vision improved to 2/60, with attached retina. The patient has been under follow-up with us for the last one year now and developed no recurrence of RD till now. This case emphasises the significance of retinoretinal adhesion in long-standing bullous RD that does not respond to conventional aggressive medical therapy.
Keyphrases
- minimally invasive
- diabetic retinopathy
- case report
- coronary artery bypass
- optical coherence tomography
- randomized controlled trial
- healthcare
- magnetic resonance imaging
- computed tomography
- rheumatoid arthritis
- blood pressure
- escherichia coli
- age related macular degeneration
- juvenile idiopathic arthritis
- combination therapy
- coronary artery disease
- acute coronary syndrome
- pseudomonas aeruginosa
- cystic fibrosis
- atrial fibrillation
- mesenchymal stem cells
- surgical site infection
- staphylococcus aureus
- percutaneous coronary intervention
- disease activity